ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 124 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $163,643 | -6.0% | 26,267 | +0.8% | 0.00% | – |
| Q3 2022 | $174,000 | +52.6% | 26,063 | +44.6% | 0.00% | – |
| Q2 2022 | $114,000 | -89.8% | 18,019 | -62.1% | 0.00% | -100.0% |
| Q3 2015 | $1,121,000 | -37.7% | 47,500 | +115.7% | 0.05% | -20.7% |
| Q2 2015 | $1,800,000 | +26.0% | 22,020 | +42.7% | 0.06% | +18.4% |
| Q1 2015 | $1,429,000 | – | 15,430 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |